Croucher, P., Hijzen, A., Shipman, C., Perry, M., Lippitt, J., Green, J., . . . Vanderkerken, K. (2001). Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
Lua i Stíl Chicago (17ú heag.)Croucher, P., A. Hijzen, C. Shipman, M. Perry, J. Lippitt, J. Green, B. Van Camp, agus K. Vanderkerken. Zoledronic Acid Inhibits the Development of Osteolytic Bone Disease and Increases Disease Free Survival in a Murine Model of Multiple Myeloma. 2001.
Lua MLA (9ú heag.)Croucher, P., et al. Zoledronic Acid Inhibits the Development of Osteolytic Bone Disease and Increases Disease Free Survival in a Murine Model of Multiple Myeloma. 2001.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.